(Q33194741)

English

Her-2/ neu altered peptide ligand?induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction

scientific article published on November 5, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Her-2/ neu altered peptide ligand-induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Her-2/ neu altered peptide ligand?induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction (English)

1 reference

10.1007/S00262-003-0439-Y

https://api.crossref.org/works/10.1007/S00262-003-0439-Y

30 March 2024

1 reference

10.1007/S00262-003-0439-Y

https://api.crossref.org/works/10.1007/S00262-003-0439-Y

30 March 2024

1 reference

10.1007/S00262-003-0439-Y

https://api.crossref.org/works/10.1007/S00262-003-0439-Y

30 March 2024

author name string

Sara O. Dionne

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605764

30 March 2024

Cheryl E. Myers

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605764

30 March 2024

Margaret H. Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605764

30 March 2024

Douglas F. Lake

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605764

30 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14605764

30 March 2024

publication date

5 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00262-003-0439-y.pdf

Portable Document Format

1 reference

10.1007/S00262-003-0439-Y

https://api.crossref.org/works/10.1007/S00262-003-0439-Y

30 March 2024

http://link.springer.com/article/10.1007/s00262-003-0439-y/fulltext.html

1 reference

10.1007/S00262-003-0439-Y

https://api.crossref.org/works/10.1007/S00262-003-0439-Y

30 March 2024

http://link.springer.com/content/pdf/10.1007/s00262-003-0439-y

1 reference

10.1007/S00262-003-0439-Y

https://api.crossref.org/works/10.1007/S00262-003-0439-Y

30 March 2024

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

307-314

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Identifiers

10.1007/S00262-003-0439-Y

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33194741&oldid=2195135256"